Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain
- PMID: 10586977
- DOI: 10.1016/s0304-3940(99)00786-7
Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain
Abstract
1,2,3,4-Tetrahydroisoquinoline (TIQ) and 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), which exist in the brain of several mammalian species, are parkinsonism-inducing substances, and 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), which is enzymatically synthesized in rat brain, is a parkinsonism-preventing substance. In this study, we examined the regional distribution of contents of TIQ, 1MeTIQ, and 1BnTIQ, and activity of 1MeTIQ-synthesizing enzyme in monkey brain. The TIQ and 1BnTIQ contents in cerebrum and substantia nigra, and the 1MeTIQ contents in striatum and substantia nigra were higher than those in other brain regions, and 1MeTIQ-synthetic activity was high in cerebrum and thalamus. We speculate that 1MeTIQ-synthesizing enzyme may play an important role in idiopathic Parkinson's disease.
Similar articles
-
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.Neurotox Res. 2016 Apr;29(3):351-63. doi: 10.1007/s12640-015-9556-6. Epub 2015 Aug 25. Neurotox Res. 2016. PMID: 26303030 Free PMC article.
-
Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.Drug Metab Dispos. 1991 Jan-Feb;19(1):257-62. Drug Metab Dispos. 1991. PMID: 1673411
-
Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.Neurotox Res. 2016 Nov;30(4):648-657. doi: 10.1007/s12640-016-9661-1. Epub 2016 Aug 27. Neurotox Res. 2016. PMID: 27568335 Free PMC article.
-
[Tetrahydroisoquinolines in connection with Parkinson's disease].Rinsho Shinkeigaku. 1989 Dec;29(12):1504-6. Rinsho Shinkeigaku. 1989. PMID: 2698297 Review. Japanese.
-
[Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain].Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Feb;25(1):39-42. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005. PMID: 15796069 Review. Japanese.
Cited by
-
An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.J Neural Transm (Vienna). 2007 Mar;114(3):307-17. doi: 10.1007/s00702-006-0546-y. Epub 2006 Aug 10. J Neural Transm (Vienna). 2007. PMID: 16897599
-
A possible physiological role for cerebral tetrahydroisoquinolines.Neurotox Res. 2003;5(1-2):147-55. doi: 10.1007/BF03033379. Neurotox Res. 2003. PMID: 12832229 Review.
-
Neurotoxicity and Underlying Mechanisms of Endogenous Neurotoxins.Int J Mol Sci. 2021 Nov 26;22(23):12805. doi: 10.3390/ijms222312805. Int J Mol Sci. 2021. PMID: 34884606 Free PMC article. Review.
-
1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.Neurotox Res. 2009 Nov;16(4):390-407. doi: 10.1007/s12640-009-9097-y. Epub 2009 Aug 1. Neurotox Res. 2009. PMID: 19649683
-
Salsolinol-neurotoxic or Neuroprotective?Neurotox Res. 2020 Feb;37(2):286-297. doi: 10.1007/s12640-019-00118-7. Epub 2019 Nov 15. Neurotox Res. 2020. PMID: 31732870 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources